What is AP-Brain collagen peptide studying for stress and cognitive function?

This trial studies how AP-Brain collagen peptide affects attention, focus, memory, and stress in adults who are stressed but otherwise healthy. Researchers compare the effects of two different doses to understand how the supplement may influence brain function and stress levels. The study is sponsored by Rousselot BVBA.

Who may be eligible for this stress and cognitive function clinical trial?

Adults aged 35 to 70 with mild cognitive impairment and moderate stress levels may be eligible. Participants must have a body mass index between 18.5 and 29.9 and report mild difficulties with focus or memory. Both males and females can participate. Please review eligibility criteria for more details.

Is there any cost to participate in this stress and cognitive function clinical trial?

Study-related care, including the study supplement and all trial visits, is provided at no cost. However, personal travel expenses may vary and are not guaranteed to be covered.

Actively Recruiting

Phase Not Applicable

Age: 35Years - 70Years

All Genders

Healthy Volunteers

ID07572240

Study of AP-Brain Collagen Peptides Effects on Attention, Focus, and Memory in Adults Aged 35 to 70 with Stress and Mild Cognitive Difficulties

Led by Rousselot BVBA · Updated on 2026-07-23

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying the effects of AP-Brain collagen peptide on attention, focus, stress, and memory in adults aged 35 to 70 who are stressed but otherwise healthy. The study aims to find out how different doses of AP-Brain affect brain function and to identify any side effects. The trial is a randomized, open-label, parallel design sponsored by Rousselot BVBA. Participants will take either a low dose one 1g tablet or a higher dose three 1g tablets of bovine-based AP-Brain collagen peptide once daily for 56 days. The study includes two groups receiving these different doses to compare their effects on cognitive abilities and stress levels. During the study, participants will visit the study center regularly for checkups. They will complete tests that measure attention, focus, and memory and answer surveys about stress. Blood samples will be collected, vital signs checked, and brain responses monitored to understand the impact of AP-Brain. The main outcome focuses on changes in attention and focus after 56 days of treatment.

CONDITIONS

Brief Title

A Clinical Trial to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals

Who Can Participate

Age: 35Years - 70Years

All Genders

Healthy Volunteers

Eligibility Criteria

You may qualify if you...

Individuals ready to give voluntary, written informed consent to participate in the study.
Male and female individuals aged 35 to 70 years.
Body mass index (BMI) between 18.5 and 29.9 kg/m².
Perceived Stress Scale (PSS) scores between 14 and 26.
Mild cognitive impairment indicated by Addenbrooke's Cognitive Examination (ACE) III scores between 75 and 88.
Self-reported mild difficulties in focus, attention, or memory.
Progressive cognitive complaints like stress or disturbed sleep reported by participant.
Willingness to consume an investigational product from bovine source.
Willingness to complete all study-related and clinical visits as per protocol.

You will not qualify if you...

Clinically diagnosed with Attention Deficit Hyperactivity Disorder (ADHD).
Diagnosed mental disorders such as epilepsy, anxiety, depression, or Alzheimer's disease.
History of cardiac, respiratory, kidney, liver, seizure disorders, or other chronic health conditions requiring medication.
Uncontrolled hypertension (systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg).
Uncontrolled diabetes (fasting blood glucose ≥ 126 mg/dl).
History of hypersensitivity to any components of the investigational product.
Use of prescription medication or dietary supplements affecting cognitive function within 30 days prior to screening.
Recent head injury causing cognitive decline.
Consumption of excessive caffeine (more than 4-5 cups per day) or caffeine-containing foods or beverages.
Current smokers.
Inability to comply with test requirements or deemed unsuitable by the investigator.
Females who are pregnant, planning pregnancy, lactating, or taking oral contraceptives.
History of drug or alcohol addiction or abuse within the past 12 months.

Research Team

Sanjay Vaze, Dr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here